CFMS News and Press, Conformis Inc. From 03/21/21

Are These Penny Stocks On Your “Buy” Or “Avoid” List This Week? We’re at the start of a brand new week and a whole new list of penny stocks to watch. One of the popular places that retail traders are searching is on Reddit. The social media discuss...

Unsurprisingly, Conformis posted a below-par set of FQ4 ’20 results as COVID-19 headwinds weighed on product sales in the knee franchise. Guidance numbers were similarly weak as COVID-19 headwinds remain a key hurdle. While the product launch cadence is positive, any execut...

Conformis (CFMS) says that an independent, retrospective review of hospital data has concluded that its Conformis iTotal knee replacement technology is more cost-effective than leading traditional, off-the-shelf implants.The review based on a financial database and electronic health...

BILLERICA, Mass., March 16, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today that an independent, retrospective review of hospital data has concluded that Conformis iTotal® knee replacement technology is more cost-effective than leading traditional, off-the-shelf ...

Are These Biotech Penny Stocks To ‘Buy’ Or Are They On The ‘Sell’ List? In the last year, many have taken an interest in biotech penny stocks. A significant driving factor of this was that many of these corporations shifted focus to creating a vaccine for the...

Schrodinger SDGR -25% on Q4 earnings release.Purple Innovation PRPL -21% on Q4 earning release.Qutoutiao QTT -20% on Q4 earning release.Yext YEXT -19% on Q4 earning release.Vroom VRM -15% on Q4 earning release.KemPharm (KMPH) -13%.Salarius Pha...

Conformis, Inc. (CFMS) Q4 2020 Results Earnings Conference Call March 03, 2021, 4:30 pm ET Company Participants Mark Augusti - President, Chief Executive Officer Bob Howe - Chief Financial Officer, Treasurer Conference Call Participants Robbie Marcus - JPMorgan Eric Anderson - Cowen Steven Li...

ConforMIS (CFMS): Q4 GAAP EPS of -$0.08 beats by $0.02.Revenue of $16.7M (-16.1% Y/Y) in-line.Shares +1.83%.Press Release For further details see: ConforMIS EPS beats by $0.02, revenue in-line

BILLERICA, Mass., March 03, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) announced today financial results for the fourth quarter and year ended December 31, 2020. Fourth Quarter 2020 Summary Total revenue of $16.7 million, a decrease of 16% year-over-year on ...

NanoViricides (NNVC) +112% on effectiveness of COVID-19 drug candidates in cell culture studies.Communications Systems (JCS) +38% after entering merger agreement with Pineapple Energy.STRATA Skin Sciences (SSKN) +30% on announcing CEO Transition.CHF Solutions (CHFS) +25%.AgeX T...